Transcreener® GDP Assay Kit for Precise Measurements of GTPase Activity

The Transcreener GTPase Assay Kit relies on direct detection of GDP produced by GTPases during GTP hydrolysis. The direct detection approach is a novel method to quantify activity of GTPases and their stimulation by related GAP and GEF proteins. Direct detection simplifies the protocol (no coupling enzyme needed) and minimizes compound interference.

Overview Transcreener GDP Assay

Image Credit: BellBrook Labs

Because the method is based on direct GDP detection, it is compatible with most GTPase targets. It is an easy-to-use and HTS-ready assay designed for screening and profiling inhibitors. The assay can be used to:

  • Measure the enzymatic activity of GTPases
  • Screen compound libraries for GTPase modulators
  • Quantify inhibitor potency
  • Inhibitor selectivity profiling
  • Measure drug-target residence time

GTPase Target Applications

The table below includes example GTPases we have validated with the Transcreener GDP Assay. Click on a target to learn more. 

GTPase Family Enzyme
Ras Family KRAS
HRAS
NRAS
RRAS
Rho Family RhoA
RhoC
Cdc42
Rac1
Ran Family Ran
Rab Family Rab2

Source: BellBrook Labs

Why Choose Transcreener?

  • Direct detection of GDP for monitoring GTPase, GAP, and GEF activity
  • Easy to use, two-step format (no coupling enzymes needed)
  • Far-red fluorescent readouts reduce compound interference
  • A non-radioactive, safe technique
  • Assay reagents are stable for at least eight hours, even at room temperature
  • Greater sensitivity and less susceptibility to interference in comparison to colorimetric phosphate detection techniques like malachite green
  • Available in an FP, FI, or TR-FRET readout depending on preference and plate reader compatibility

Example Data Using KRAS GTPase

Detecting GDP Under Initial Velocity Conditions with Varying EDTA Concentrations

KRAS Titration with Varying EDTA Concentrations

KRAS enzyme titration with varying EDTA concentrations using the Transcreener GDP FP Assay. Assay conditions include 2 µM GTP, 20 mM Tris pH 7.5, 50 mM NaCl, 5 mM MgCl2, 0.1 mg/mL BSA, and 1 mM DTT. The Detection mix included 1X Stop & Detect Buffer B, 10 μg/mL GDP antibody, and 4 nM GDP Alexa 633 tracer. 

Image Credit: BellBrook Labs

KRAS Linear Response with Varying EDTA Concentrations

KRAS linear response with varying EDTA concentrations using the Transcreener GDP FP Assay. The assay demonstrates linearity when raw data is converted to GDP using a standard curve.

Image Credit: BellBrook Labs

Detecting GDP Under Initial Velocity Conditions with Varying Enzyme Reaction Times

KRAS Titration with Varying Enzyme Reaction Times

KRAS enzyme titration with varying enzyme reactions time (60 min, 120 min, and 180 min) using the Transcreener GDP FP Assay. Assay conditions include 2 µM GTP, 20 mM Tris pH 7.5, 50 mM NaCl, 5 mM MgCl2, 0.1 mg/mL BSA, and 1 mM DTT. The Detection mix included 1X Stop & Detect Buffer B, 10 μg/mL GDP antibody, and 4 nM GDP Alexa 633 tracer. 

Image Credit: BellBrook Labs

KRAS Linear Response with Varying Enzyme Reaction Times

KRAS linear response with varying enzyme reactions time (60 min, 120 min, and 180 min) using the Transcreener GDP FP Assay. The assay demonstrates linearity when raw data is converted to GDP using a standard curve. 

Image Credit: BellBrook Labs

GTPase Profiling Services

BellBrook Labs also offers GTPase profiling services for scientists who want to move their program forward, but don't want to bring an assay in-house. This can include testing compounds at a single concentration or in dose-response mode for the determination of IC50 values. Their services feature customizable assay conditions, quick turnaround times, and direct collaboration with a BellBrook scientist.

Other Equipment by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.